Arbor Biotechnologies is pioneering next-generation gene editing to revolutionize the treatment of genetic diseases. The company focuses on discovering and developing genomic medicines that address the root causes of these diseases, utilizing a diverse toolbox of novel gene editors. With a commitment to curing all patients suffering from genetic conditions, Arbor is positioned at the forefront of the biotech industry, leveraging advanced technologies to rewrite the human genome and provide functional cures.

Cambridge, MA, USA

Arbor Biotechnologies

Therapeutics

S32 is a venture capital fund founded by Bill Maris.

Section 32, LLC

Tell us about your professional DNA to get discovered by any company in our network with opportunities relevant to your career goals.

Leverage our network to build your career.

#### Welcome!

Thank you for joining Section 32 Network!

To help us best support you in your search, please take a few minutes to tell us about what you are looking for in your next role. We’ll use this information to connect you to relevant opportunities in the Section 32 network as they come up.

You can always update this information later.

Welcome to the Section 32 talent network

As our companies grow, they look to us to help them find the best talent.

Signal that you'd be interested in working with a Section 32 company to help us put the right opportunities at great companies on your radar. The choice to pursue a new career move is then up to you.

Your professional information is now visible to our team and companies in our network.
We will be in touch when we find a great opportunity for you at one of our companies.

Thanks for signing up

As our companies grow, they look to us to help them find the best talent.
Signal that you'd be interested in working with a Section 32 company to help us put the right opportunities at great companies on your radar. The choice to pursue a new career move is then up to you.